Growth Metrics

Hims & Hers Health (HIMS) Shares Outstanding (Weighted Average) (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $225.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 4.18% to $225.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $225.0 million through Dec 2025, up 4.18% year-over-year, with the annual reading at $225.0 million for FY2025, 4.18% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $225.0 million in Q4 2025 for Hims & Hers Health, roughly flat from $224.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $225.0 million in Q4 2025 to a low of $153.1 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $206.8 million across 5 years, with a median of $208.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 465.94% in 2021 and later grew 1.96% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $186.8 million in 2021, then grew by 9.49% to $204.5 million in 2022, then rose by 2.36% to $209.3 million in 2023, then increased by 3.15% to $215.9 million in 2024, then grew by 4.18% to $225.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for HIMS at $225.0 million in Q4 2025, $224.3 million in Q3 2025, and $224.4 million in Q2 2025.